Dermatriz Editorial Insights | October 2026
Why nucleotide-based ingredients are attracting attention
Polynucleotides (PNs) and polydeoxyribonucleotides (PDRN) have become prominent topics in regenerative and aesthetic dermatology. Their proposed roles relate to skin quality, repair and the biological response to tissue stress. Yet similar ingredient names appear across injectable products, professional solutions and topical cosmetics—categories that should not be treated as interchangeable.
What the latest evidence covers
A 2026 systematic review of seven randomised trials involving 183 participants reported promising outcomes across skin rejuvenation, scar-related measures and wound healing, with the most consistent signals in wound-healing settings. The authors also emphasised the limited size and diversity of the evidence base. These studies do not automatically validate every commercial PDRN formulation or every route of administration.
Why delivery method matters
Formulation, concentration, delivery, skin condition and regulatory classification can materially affect the relevance of a study. Evidence from injected PN or PDRN treatments cannot be assumed to demonstrate the same effects from a cosmetic serum applied to intact skin. Professional providers should evaluate technical documentation and any clinical substantiation specific to a product.
Relevant portfolio discussion
SKINDERMA PDRN + HA formulations are part of Dermatriz’s professional range. The company’s broader portfolio also includes regeneration- and hydration-positioned skincare. Any communication about individual products should stay within their actual documented use and claims, without implying that peer-reviewed results for a different preparation apply directly.
Editorial takeaway
The next phase for PDRN is evidence quality rather than hype: clearer trials, longer follow-up and product-specific evaluation will help professionals decide where these technologies truly belong.
Sources & Further Reading
- Polynucleotides and PDRN: Systematic Review of Randomized Clinical Trials (2026)
- Nucleotide-Based Skin Boosters in Aesthetic Dermatology (2026)
Editorial note: This article is for general professional education. It is not individual medical advice. Brand mentions are illustrative; cited studies do not establish clinical efficacy for any named Dermatriz product unless explicitly stated.
